SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-008037
Filing Date
2022-03-01
Accepted
2022-03-01 16:12:00
Documents
14
Period of Report
2022-03-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rgnx-8k_20220301.htm   iXBRL 8-K 35604
2 EX-99.1 rgnx-ex991_24.htm EX-99.1 435770
3 GRAPHIC gflgolglbl1f000001.jpg GRAPHIC 15901
  Complete submission text file 0001564590-22-008037.txt   641752

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA rgnx-20220301.xsd EX-101.SCH 5681
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgnx-20220301_lab.xml EX-101.LAB 18663
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgnx-20220301_pre.xml EX-101.PRE 11118
8 EXTRACTED XBRL INSTANCE DOCUMENT rgnx-8k_20220301_htm.xml XML 3418
Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37553 | Film No.: 22698106
SIC: 2836 Biological Products, (No Diagnostic Substances)